Invention Grant
- Patent Title: Inhibitors of Akt activity
-
Application No.: US12526111Application Date: 2008-02-07
-
Publication No.: US08410158B2Publication Date: 2013-04-02
- Inventor: Mark A. Seefeld , Meagan B. Rouse , Dirk A. Heerding
- Applicant: Mark A. Seefeld , Meagan B. Rouse , Dirk A. Heerding
- Applicant Address: US PA Philadelphia
- Assignee: GlaxoSmithKline LLC
- Current Assignee: GlaxoSmithKline LLC
- Current Assignee Address: US PA Philadelphia
- Agent Wayne J. Dustman; Edward R. Gimmi
- International Application: PCT/US2008/053269 WO 20080207
- International Announcement: WO2008/098104 WO 20080814
- Main IPC: A01N43/56
- IPC: A01N43/56 ; A61K31/415
Abstract:
Invented are novel heterocyclic carboxamide compounds, the use of such compounds as inhibitors of protein kinase B activity and in the treatment of cancer and arthritis.
Public/Granted literature
- US20100267759A1 INHIBITORS OF Akt ACTIVITY Public/Granted day:2010-10-21
Information query
IPC分类:
